Skip to Content
Find More Like This
Return to Search

Bacteriophage Host-Range Expansion

Sandia National Laboratories

Contact SNL About This Technology

Publications:

PDF Document PublicationBacteriophage v. 1.pdf (513 KB)


Technology Marketing SummaryDecades of widespread antibiotic use has created antibiotic-resistant strains of bacteria that are becoming increasingly difficult to treat. In 2006, the Food and Drug Administration (FDA) approved the use of bacteriophages (phages) for food industry applications to eliminate the presence of bacteria, such as Listeria, E.coli, and Salmonella. Phages have also been approved for agricultural use as an alternative to chemical pesticides, and phage treatment is popular in other countries to treat bacterial infections in humans.DescriptionAs phages are host-specific, searching for, isolating, and propagating phages to target specific “problem” bacterial strains can be challenging and time-consuming. Manufacturers of phage treatments have created phage “cocktails”, each containing dozens of phage strains to combat a single, specific bacterial strain. In order to receive FDA approval, each phage variant in these cocktails must be individually tested, which can take an extended amount of time. Rather than searching the environment for bacteriophages specific to a particular bacterial strain, Sandia researchers developed a method to propagate known phage strains and mutate them in a way that expands their host-range. This method allows known phage strains to be modified to infect specific strains of bacteria. Mutant phage can become more effective against their natural hosts as well as against a wider range of hosts. By combining strains of mutant phages, problematic bacteria will be infected in multiple modes, overwhelming them and killing the entire bacterial population. By using mutant phages with broader host-ranges, the number of phage strains required for a cocktail would decrease, which, in turn, would speed up the FDA approval process. By broadening the use of currently known phage strains to fight more diverse bacterial variants, phages can be used as an alternative to, or in conjunction with, antibiotics.Benefits

• Creates bacteriophage strains with increased host-range

• Reduces the number of phage strains needed in bacteriophage cocktails (speeding up the FDA approval process)

• Creates ability to mutate known phage strains for specific bacteria of interest

Applications and Industries

• Healthcare

• Agriculture

• Food safety & processing

• Hospital Sterilization

• Veterinary

Technology Status
Technology IDDevelopment StageAvailabilityPublishedLast Updated
SD#13347Prototype - Sandia estimates this technology at a Technology Readiness Level 4. Basic technological components are integrated to establish that the pieces will work together.Available10/31/201610/31/2016

Contact SNL About This Technology

To: <ip@sandia.gov>